286 related articles for article (PubMed ID: 26825607)
1. Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets.
Schindlbeck C; Andergassen U; Jueckstock J; Rack B; Janni W; Jeschke U
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1883-95. PubMed ID: 26825607
[TBL] [Abstract][Full Text] [Related]
2. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
3. Review: Biological relevance of disseminated tumor cells in cancer patients.
Riethdorf S; Wikman H; Pantel K
Int J Cancer; 2008 Nov; 123(9):1991-2006. PubMed ID: 18712708
[TBL] [Abstract][Full Text] [Related]
4. Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.
Schindlbeck C; Andergassen U; Hofmann S; Jückstock J; Jeschke U; Sommer H; Friese K; Janni W; Rack B
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1055-62. PubMed ID: 23525580
[TBL] [Abstract][Full Text] [Related]
5. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer.
Wiedswang G; Borgen E; Schirmer C; Kåresen R; Kvalheim G; Nesland JM; Naume B
Int J Cancer; 2006 Apr; 118(8):2013-9. PubMed ID: 16287086
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.
Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Diéras V; Mathiot C; Mignot L; Thiery JP; Sastre-Garau X; Pierga JY
Ann Oncol; 2008 Mar; 19(3):496-500. PubMed ID: 18187488
[TBL] [Abstract][Full Text] [Related]
9. Disseminated and circulating tumor cells: Role in effective cancer management.
Lin H; Balic M; Zheng S; Datar R; Cote RJ
Crit Rev Oncol Hematol; 2011 Jan; 77(1):1-11. PubMed ID: 20570170
[TBL] [Abstract][Full Text] [Related]
10. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
11. Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.
Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Rodrigues M; Diéras V; Mignot L; Sastre-Garau X; Poupon MF; Pierga JY
Clin Exp Metastasis; 2008; 25(8):871-5. PubMed ID: 18989740
[TBL] [Abstract][Full Text] [Related]
12. [Detection of disseminated tumor cells in the bone marrow of breast cancer patients with a new molecular method].
Banyś M; Krawczyk N; Becker S; Becker-Pergola G; Banyś J; Krawczyk Z; Wallwiener D; Fehm T
Ginekol Pol; 2012 Aug; 83(8):590-7. PubMed ID: 23342882
[TBL] [Abstract][Full Text] [Related]
13. Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer.
Tewes M; Kasimir-Bauer S; Welt A; Schuler M; Kimmig R; Aktas B
J Cancer Res Clin Oncol; 2015 Jan; 141(1):87-92. PubMed ID: 25108406
[TBL] [Abstract][Full Text] [Related]
14. Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies.
Müller V; Alix-Panabières C; Pantel K
Eur J Cancer; 2010 May; 46(7):1189-97. PubMed ID: 20347588
[TBL] [Abstract][Full Text] [Related]
15. Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies.
Banys M; Solomayer EF; Becker S; Krawczyk N; Gardanis K; Staebler A; Neubauer H; Wallwiener D; Fehm T
Int J Gynecol Cancer; 2009 Jul; 19(5):948-52. PubMed ID: 19574790
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells.
Schmitt M; Foekens JA
Breast Cancer Res; 2009; 11(5):109. PubMed ID: 19833005
[TBL] [Abstract][Full Text] [Related]
17. DTCs in breast cancer: clinical research and practice.
Janni W; Rack B; Kasprowicz N; Scholz C; Hepp P
Recent Results Cancer Res; 2012; 195():173-8. PubMed ID: 22527504
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.
Schindlbeck C; Kampik T; Janni W; Rack B; Jeschke U; Krajewski S; Sommer H; Friese K
Breast Cancer Res; 2005; 7(6):R1174-85. PubMed ID: 16457698
[TBL] [Abstract][Full Text] [Related]
19. Rating of isolated disseminated tumor cells in bone marrow in comparison with other factors of prognosis in breast carcinoma.
Leinung S; Würl P; Schönfelder A; Weiss CL; Röder I; Schönfelder M
Int J Surg Investig; 2000; 2(3):193-202. PubMed ID: 12678519
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Sommer H; Friese K
Histochem Cell Biol; 2005 Jun; 123(6):631-7. PubMed ID: 15889266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
